[HTML][HTML] Ten-year Time-trend Analysis of Dyslipidemia Among Adults in Wuhan

M Zhang, Z Wan, Y Lv, Y Huang, L Hu, H Xu… - Current Medical …, 2022 - Springer
Objective Dyslipidemia is associated with an increased risk of cardiovascular disease, the
major cause of death in an aging population. This study aimed to estimate the prevalence of …

[引用][C] Epidemiological analysis of dyslipidemia in adults of three ethnicities in Xinjiang, China

SX Guo, RL Ma, H Guo, YS Ding, JM Liu, M Zhang… - Genet Mol Res, 2014

[PDF][PDF] Serum lipid levels and the prevalence of dyslipidaemia among rural and urban Thai adults-Are the NCEP III guidelines appropriate?

A Patel, M Woodward, R Stolk… - Journal-Medical …, 2005 - thaiscience.info
The authors' objective was to describe the distribution of serum lipids and the prevalence of
dyslipidaemia using US lipid-lowering guidelines in an adult Thai population. Fasting serum …

The prevalence, awareness, and treatment of lipid abnormalities in Iranian adults: Surveillance of risk factors of noncommunicable diseases in Iran 2016

Z Aryan, N Mahmoudi, A Sheidaei, S Rezaei… - Journal of clinical …, 2018 - Elsevier
Background Hypercholesterolemia is one of the modifiable risk factors for atherosclerosis
and cardiovascular diseases. Prevention and treatment of hypercholesterolemia and other …

Prevalence, treatment and control of dyslipidaemia in Switzerland: still a long way to go

M Firmann, P Marques-Vidal, F Paccaud… - European Journal of …, 2010 - academic.oup.com
Background There is little information regarding the prevalence and management of
dyslipidaemia in Switzerland. Design Cross-sectional population-based study of 3238 …

[HTML][HTML] Public perceptions and knowledge of cholesterol management in a multi-ethnic Asian population: A population-based survey

CY Lim, JS Ho, Z Huang, F Gao, SY Tan, WP Koh… - Plos one, 2021 - journals.plos.org
Introduction Cardiovascular diseases (CVDs) are the leading cause of mortality worldwide.
Hyperlipidemia is one of the important modifiable risk factors for CVDs. Raising public …

Investigation on status of dyslipidemia in Chinese females aged 35 years or above

MY Ma, XL Chen, Z Chen, X Wang… - Zhonghua xin xue …, 2022 - europepmc.org
Objective: To investigate the prevalence, awareness, treatment and control status of
dyslipidemia among females aged≥ 35 years old across China. Methods: Participants were …

[PDF][PDF] Hypercholesterolemia prevalence, awareness, treatment and control among adults in Malaysia: the 2015 National Health and Morbidity Survey, Malaysia

HM Rifin, TGR Lourdes, NL Ab Majid… - Glob. J. Health …, 2018 - academia.edu
Abstract Background & Objective: Dyslipidaemia is one of the main modifiable risk factors for
cardiovascular disease (CVD). Therefore, it is crucial to examine the prevalence …

Relationship between dyslipidemia and diabetes mellitus among adult residents in Jiangsu province

R TAO, J ZHOU, J SU - Chinese Journal of Public Health, 2015 - zgggws.com
ObjectiveTo explore the relationship between dyslipidemia and diabetes mellitus in adult
residents of Jiangsu province, and to provide a scientific basis for formulating strategies and …

[HTML][HTML] Dyslipidemia in primary care–prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS)

E Steinhagen-Thiessen, P Bramlage, C Lösch… - Cardiovascular …, 2008 - Springer
Background Current guidelines from the European Society of Cardiology (ESC) define low
thresholds for the diagnosis of dyslipidemia using total cholesterol (TC) and LDL-cholesterol …